This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Hill S, Millard R, Corcos J, Teloken C, Lheritier K, Slack M.Long-term darifenacin treatment for OAB in the geriatric population: QoL outcomes from a 2-year, open-label extension study. 13th Annual Conference of the International Society for Quality of Life Research 15 (Suppl.): 71, Oct 2006. Available from: URL: http://www.isoqol.org
Rights and permissions
About this article
Cite this article
Darifenacin improves HRQOL in patients with OAB. Pharmacoecon. Outcomes News 517, 9 (2006). https://doi.org/10.2165/00151234-200605170-00022
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200605170-00022